Uppsala, Sweden, March 12, 2013 – Molecular tools specialist Olink today launched Proseek® Multiplex - a new generation of multiplexed protein biomarker immunoassays based on its proprietary Proximity Extension Assay (PEA) platform. Until now, it has been impossible to scale up conventional assays due to increased antibody cross-reactivity when large numbers of assays are run simultaneously.
Duolink
"In-cell Co-IP"
Visualize stable and transient interactions at endogenous protein levels directly in situ.
Read more ›Proseek
The 1 µl "ELISA"
Sensitive protein quantification in only 1 µl of plasma using real-time PCR.
Read more ›
CASE
Read more ›
Subcellular localization of protein interactions and modifications
"The Duolink kit has become a standard method in our lab for the detection and quantification of protein interactions.."
Susanne Vetterkind, PhD, Boston University, Boston
CASE
Read more ›
Novel biomarker research studies
“The low sample consumption and overall immunoassay performance of Proseek has enabled us to...”
Jan Stenvang, PhD, University of Copenhagen, Denmark
News
Welcome to Olink Bioscience
Olink Bioscience develops, manufactures, and markets unique and highly innovative proprietary products for biomarker research and development. Together with our customers and collaborators we aim to improve clinical decision making by the use of molecular biomarkers. Our groundbreaking tools gain new insights in disease processes, improve disease detection, and contribute to a better understanding of biology. Read more ›
